Intensity Therapeutics, Inc. (INTS)
3.35
-0.03
(-0.89%)
USD |
NASDAQ |
Oct 16, 16:00
3.27
-0.08
(-2.39%)
After-Hours: 20:00
Intensity Therapeutics Market Cap : 9.868M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 9.868M |
| October 15, 2026 | 9.956M |
| October 14, 2026 | 10.07M |
| October 13, 2026 | 10.46M |
| October 12, 2026 | 9.750M |
| October 09, 2026 | 10.69M |
| October 08, 2026 | 10.84M |
| October 07, 2026 | 11.19M |
| October 06, 2026 | 10.46M |
| October 05, 2026 | 10.16M |
| October 02, 2026 | 10.13M |
| October 01, 2026 | 9.455M |
| September 30, 2026 | 9.927M |
| September 29, 2026 | 10.07M |
| September 28, 2026 | 10.75M |
| September 25, 2026 | 11.19M |
| September 24, 2026 | 11.46M |
| September 23, 2026 | 12.08M |
| September 22, 2026 | 11.81M |
| September 21, 2026 | 11.84M |
| September 18, 2026 | 12.11M |
| September 17, 2026 | 11.43M |
| September 16, 2026 | 11.22M |
| September 15, 2026 | 11.22M |
| September 14, 2026 | 11.72M |
| Date | Value |
|---|---|
| September 11, 2026 | 11.84M |
| September 10, 2026 | 11.90M |
| September 09, 2026 | 11.84M |
| September 08, 2026 | 12.05M |
| September 04, 2026 | 12.08M |
| September 03, 2026 | 11.78M |
| September 02, 2026 | 11.78M |
| September 01, 2026 | 11.99M |
| August 31, 2026 | 12.40M |
| August 28, 2026 | 12.52M |
| August 27, 2026 | 12.58M |
| August 26, 2026 | 13.34M |
| August 25, 2026 | 14.42M |
| August 24, 2026 | 13.99M |
| August 21, 2026 | 14.32M |
| August 20, 2026 | 14.37M |
| August 19, 2026 | 12.37M |
| August 18, 2026 | 12.40M |
| August 17, 2026 | 12.22M |
| August 14, 2026 | 11.66M |
| August 13, 2026 | 11.78M |
| August 12, 2026 | 12.25M |
| August 11, 2026 | 12.37M |
| August 10, 2026 | 12.64M |
| August 07, 2026 | 12.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 7.889B |
| Oncolytics Biotech, Inc. | 62.08M |
| Sangamo Therapeutics, Inc. | 45.65M |
| Sarepta Therapeutics, Inc. | 1.806B |
| Anixa Biosciences, Inc. | 92.34M |
Market Cap Related Metrics
| Price to Book Value | 1.071 |
| Price | 3.35 |
| Earnings Yield | -144.2% |